# The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024, Regulation 8: Amendment to regulation B17

Extent: E+W+S+N.I.

In regulation B17(2)(b) (regulations on good manufacturing practice), omit “or EU marketing authorisation”.

---
Source: https://www.legislation.gov.uk/uksi/2024/832/regulation/8 (the official version)
Page: https://openlegislation.uk/human-medicines-amendments-relating-to-the-windsor-framework-regulations-2024/regulation-8
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.